4.7 Review

Transgenic rice endosperm as a bioreactor for molecular pharming

Journal

PLANT CELL REPORTS
Volume 33, Issue 4, Pages 585-594

Publisher

SPRINGER
DOI: 10.1007/s00299-013-1559-2

Keywords

Molecular pharming; Transgenic rice; endosperm; Plant-made pharmaceutical (PMP); Manufacturing of PMP

Categories

Ask authors/readers for more resources

Plants provide a promising expression platform for producing recombinant proteins with several advantages in terms of high expression level, lower production cost, scalability, and safety and environment-friendly. Molecular pharming has been recognized as an emerging industry with strategic importance that could play an important role in economic development and healthcare in China. Here, this review represents the significant advances using transgenic rice endosperm as bioreactor to produce various therapeutic recombinant proteins in transgenic rice endosperm and large-scale production of OsrHSA, and discusses the challenges to develop molecular pharming as an emerging industry with strategic importance in China.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available